Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Terminated 4Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 23Leukemia 3Recurrence 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Myeloid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Higher-risk Myelodysplastic Syndrome 1Hematologic Diseases 1Dendritic Cell Sarcoma, Interdigitating 1Bone Marrow Diseases 1

Interventions

Cyclophosphamide 10Rituximab 9polatuzumab vedotin 6Prednisone 6Doxorubicin 6glofitamab 5Vincristine 5zanubrutinib 4Prednisolone 4Lenalidomide 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Lisaftoclax 3tafasitamab 2obinutuzumab 2fludarabine 2Radiotherapy 2R-CHOP protocol 2Observation 2venetoclax 1sintilimab 1resiniferatoxin 1penpulimab 1pegfilgrastim 1orelabrutinib 1loncastuximab tesirine 1duvelisib 1acalabrutinib 1Vancomycin 1Therapeutics 1Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Large B-Cell, Diffuse × Azacitidine × Clear all
NCT06778902 2025-01-16

Dragon

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 2 Not yet recruiting
80 enrolled
LymphoidSarcoma

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡